Dr. Durrant is a Professor in the Departments of Communication Science and Disorders, Otolaryngology, and Rehabilitation Science and Technology, University of Pittsburgh. He is Adjunct Professor of Speech and Hearing Science at the Ohio State University. He is also an international scholar, having held academic posts in the Claude Bernard University (University of Lyon--1, France) where he enjoys ongoing collaborations.

He is vice chair of the International Evoked Response Audiometry Study Group, chaired ASHA's (American Speech-Language-Hearing Association's) working group on evoked potential measurement (leading to a statement of clinical competencies), and has served on several working groups of the American National Standards Institute. He has served as a reviewer of numerous grants and research articles, is an associate editor for an international journal of audiology, and is a former member of the Veterans Administration Merit Review, Neurobiology Subcommittee.

He has 65 peer-reviewed publications, 46 text chapters and other academic publications, and one published text. Prof. Durrant is a fellow of ASHA and the American Academy of Audiology. As the former chief of audiology in the medical schools of Temple University and, subsequently, the University of Pittsburgh (Department of Otolaryngology), he has over 20 years experience as a clinical director. He has, in particular, extensive experience in clinical audiological methods, coordination of clinical services, program development, and clinical research, in addition to his robust background in basic hearing science (in particular, physiological acoustics) and applied/clinical research in audiology. He trained in the speech and hearing sciences at Ohio and Northwestern Universities.

Over his career, between Temple and Pitt, he has served as principal and co-investigator of various externally funded and other research projects, has mentored numerous graduate students (master's and doctoral level), residents and post-graduate or visiting fellows, and has substantial experience in technology-transfer research and development. He is currently the PI of a science and technology transfer research project (Phase II) sponsored by the National Institutes of Health. Prof. Durrant also bears substantial teaching responsibilities in the CS&D Department, including in the audiology graduate training program (e.g. hearing science, signals and noise analysis, and objective auditory measures).

Although his past primary area of expertise and publication was in electrocochleography and measurement/assessment of brain-stem (short-latency) potentials and related issues, he since has carried out investigations and mentored or collaborated in work of others in the areas of middle and long-latency potentials (stimulus and event-related) and vestibular function. Also, he participated actively on an implant team for over a decade, including a clinical trial (brain-stem implant), and other projects pertaining to intra-operative monitoring.

Over the past decade, he has become increasingly involved clinically and in research and development of otoacoustic emission assessment. This, indeed, is a primary focus of his current NIH-STTR project which, in turn, is targeted at audiovestibular ototoxicity monitoring.